Cargando…

Chemotherapy for ovarian cancer--trials, controversies and funding.

Detalles Bibliográficos
Autor principal:	Hawkins, R. E.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group\|1 1998
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063227/ https://www.ncbi.nlm.nih.gov/pubmed/9836469

Ejemplares similares

First-line chemotherapy for ovarian cancer – the controversy continues
por: Kaye, S B
Publicado: (2002)

Controversies in borderline ovarian tumors
por: Seong, Seok Ju, et al.
Publicado: (2015)

First-line treatment of ovarian cancer: questions and controversies to address
por: Ledermann, Jonathan A.
Publicado: (2018)

Screening for prostate cancer: Controversy? What controversy?
por: Ablin, R.J., et al.
Publicado: (2009)

Hyperthermic Intraperitoneal Chemotherapy (HIPEC): New Approaches and Controversies on the Treatment of Advanced Epithelial Ovarian Cancer—Systematic Review and Meta-Analysis
por: Della Corte, Luigi, et al.
Publicado: (2023)

Controversies Regarding Ovarian Suppression and Infertility in Early Stage Breast Cancer
por: Durrani, Sajid, et al.
Publicado: (2020)

Controversies and consensus of neoadjuvant chemotherapy in soft-tissue sarcomas
por: Loong, Herbert H., et al.
Publicado: (2018)

Adjuvant chemotherapy in soft tissue sarcomas…Conflicts, consensus, and controversies
por: Bajpai, Jyoti, et al.
Publicado: (2016)

Three ongoing intraperitoneal chemotherapy trials in ovarian cancer
por: Fujiwara, Keiichi
Publicado: (2012)

Controversies in the treatment of advanced ovarian cancer in the PARP inhibitors era: a Delphi consensus
por: Redondo, Andrés, et al.
Publicado: (2023)

Phase I trial of ribociclib with platinum chemotherapy in ovarian cancer
por: Coffman, Lan G., et al.
Publicado: (2022)

Predicting response to neoadjuvant chemotherapy in bladder cancer: controversies remain with genomic DNA sequencing
por: Seiler, Roland
Publicado: (2016)

Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy
por: Ács, Balázs, et al.
Publicado: (2017)

Preface: controversies in breast cancer
por: Miller, William R
Publicado: (2007)

Controversies in Breast Cancer 2008
por: Miller, William R
Publicado: (2008)

Controversies in Breast Cancer 2010
por: Miller, William R
Publicado: (2010)

Controversies in Breast Cancer 2009
por: Miller, William R
Publicado: (2009)

What does decreased funding for science mean to the United States?
por: Hawkins, T R
Publicado: (1995)

Chemotherapy for Elderly Ovarian Cancer Patients
por: Muralikrishnan, Sivraj, et al.
Publicado: (2016)

What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies
por: McDonald, Alison M, et al.
Publicado: (2006)

Controversies in the management of cysticercosis.
por: Evans, C, et al.
Publicado: (1997)

Controversies in the Management of Endometrial Cancer
por: Masciullo, V., et al.
Publicado: (2010)

Controversies in Surgical Staging of Endometrial Cancer
por: Seracchioli, R., et al.
Publicado: (2010)

Controversies in the treatment of RAS wild-type metastatic colorectal cancer
por: Vera, R., et al.
Publicado: (2020)

Controversy
Publicado: (1872)

Controversies
Publicado: (1896)

Controversy
Publicado: (1856)

Gynaecologic Oncology Controversies in Cancer Treatment
por: Hunter, R.
Publicado: (1982)

Aducanumab: evidence from clinical trial data and controversies
por: Tampi, Rajesh R, et al.
Publicado: (2021)

To fund or not to fund?
por: Shailes, Sarah
Publicado: (2017)

Progress and controversies in developing cancer vaccines
por: Slingluff, Craig L, et al.
Publicado: (2005)

Review of current controversial issues in clinical trials
por: Chow, Shein-Chung, et al.
Publicado: (2021)

Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions
por: Haddad, R I, et al.
Publicado: (2018)

Psychosocial controversies in breast cancer
por: Fallowfield, Lesley
Publicado: (2007)

Controversies on autoimmunity and prognosis in cancer
por: Ferretti, G, et al.
Publicado: (2006)

Controversies in the Management of Endometrial Cancer
por: Hernandez, Enrique, et al.
Publicado: (2010)

Chemotherapy for ovarian cancer--a consensus statement on standard practice.
por: Adams, M., et al.
Publicado: (1998)

Chemotherapy of ovarian cancer in elderly patients
por: Troso-Sandoval, Tiffany A., et al.
Publicado: (2015)

Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group.
por: Aabo, K., et al.
Publicado: (1998)

Biological Insights into Chemotherapy Resistance in Ovarian Cancer
por: Glasgow, Michelle A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_04ofau1vfs60kv7pdcchoo5s9v